Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York, 10032, USA.
Am J Psychiatry. 2010 Dec;167(12):1456-63. doi: 10.1176/appi.ajp.2010.10040570. Epub 2010 Aug 4.
The authors investigated recent trends in the use of outpatient psychotherapy in the United States.
Service use data from two representative surveys of the U.S. general population, the 1998 (N=22,953) and 2007 (N=29,370) Medical Expenditure Panel Surveys, were analyzed, focusing on individuals who made more than one outpatient psychotherapy visit during that calendar year. The authors computed rates of any psychotherapy use; percentages of persons treated for mental health conditions with only psychotherapy, only psychotropic medication, or their combination; the mean number of psychotherapy visits of persons receiving psychotherapy; and psychotherapy expenditures.
The percentage of persons using outpatient psychotherapy was 3.37% in 1998 and 3.18% in 2007 (adjusted odds ratio=0.95, 95% CI=0.82-1.09). Among individuals receiving outpatient mental health care, use of only psychotherapy (15.9% and 10.5% in 1998 and 2007, respectively; adjusted odds ratio=0.66, 95% CI=0.48-0.90) as well as psychotherapy and psychotropic medication together (40.0% and 32.1%; adjusted odds ratio=0.73, 95% CI=0.59-0.90) declined while use of only psychotropic medication increased (44.1% and 57.4%; adjusted odds ratio=1.63, 95% CI=1.32-2.00). Declines occurred in annual psychotherapy visits per psychotherapy patient (mean values, 9.7 and 7.9; adjusted β=-1.53, p<0.0001), mean expenditure per psychotherapy visit ($122.80 and $94.59; β=28.21, p<0.0001), and total national psychotherapy expenditures ($10.94 and $7.17 billion; z=2.61, p=0.009).
During the decade from 1998 to 2007, the percentage of the general population who used psychotherapy remained stable. Over the same period, however, psychotherapy assumed a less prominent role in outpatient mental health care as a large and increasing proportion of mental health outpatients received psychotropic medication without psychotherapy.
作者调查了美国门诊心理治疗使用的最新趋势。
利用美国一般人群的两项代表性调查(1998 年,N=22953;2007 年,N=29370)中的服务使用数据进行分析,重点关注当年接受多次门诊心理治疗的个体。作者计算了任何心理治疗使用的比例;仅接受心理治疗、仅接受精神药物治疗或同时接受两者治疗的心理健康状况治疗者的百分比;接受心理治疗者的平均心理治疗次数;以及心理治疗支出。
1998 年和 2007 年,使用门诊心理治疗的患者比例分别为 3.37%和 3.18%(调整后比值比=0.95,95%CI=0.82-1.09)。在接受门诊心理健康护理的个体中,仅接受心理治疗(1998 年和 2007 年分别为 15.9%和 10.5%;调整后比值比=0.66,95%CI=0.48-0.90)以及同时接受心理治疗和精神药物治疗(40.0%和 32.1%;调整后比值比=0.73,95%CI=0.59-0.90)的比例下降,而仅接受精神药物治疗的比例上升(44.1%和 57.4%;调整后比值比=1.63,95%CI=1.32-2.00)。每位接受心理治疗的患者每年接受的心理治疗次数(平均值分别为 9.7 和 7.9;调整后β=-1.53,p<0.0001)、每次心理治疗的平均支出(分别为 122.80 美元和 94.59 美元;β=28.21,p<0.0001)和全国心理治疗总支出(分别为 10.94 亿美元和 7.17 亿美元;z=2.61,p=0.009)也有所下降。
在 1998 年至 2007 年的十年间,使用心理治疗的普通人群比例保持稳定。然而,在同一时期,心理治疗在门诊心理健康护理中的作用变得不那么突出,因为越来越多的精神科门诊患者在没有接受心理治疗的情况下接受精神药物治疗。